We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
John
Reid
john.reid@borders.scot.nhs.uk
Dr
John
Reid
john.reid@borders.scot.nhs.uk
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Pulmonary embolism may only partially resolve leading to significant morbidity in the form of post embolic pulmonary hypertension. This is often not identified early enough to allow helpful modification of anticoagulation. We propose using the latest and most powerful CT and software to assess unresolved thrombi and demonstrate residual perfusion defects to help identify thoase at most risk.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Not Specified;
You can take part if:
You may not be able to take part if:
To be added
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Edinburgh and funded by Chest Heart and Stroke Scotland .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 10299
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
